Headache Inducing Effect of Cromakalim in Migraine Patients

• Status: Completed
• Trial end date: 2017-11-30
• Target enrollment: 0
• Participant gender: All

Summary

To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Danish Headache Center
• Treatments: Cromakalim

Criteria

Inclusion Criteria:

• Migraine patients of both sexes.

• 18-60 years.

• 50-90 kg.

• Women of childbearing potential must use adequate contraception.

Exclusion Criteria:

• Headache less than 48 hours before the tests start

• Daily consumption of drugs of any kind other than oral contraceptives

• Pregnant or nursing women.

• Cardiovascular disease of any kind, including cerebrovascular diseases.